Department of Immunology and Microbiology, Wayne State University School of Medicine, Detroit, Michigan, USA.
Department of Immunology and Microbiology, Wayne State University School of Medicine, Detroit, Michigan, USA Department of Biological Sciences, College of Liberal Arts and Sciences, Wayne State University, Detroit, Michigan, USA.
J Virol. 2014 Aug;88(16):9086-99. doi: 10.1128/JVI.01141-14. Epub 2014 Jun 4.
Human cytomegalovirus (HCMV) has many effects on cells, including remodeling the cytoplasm to form the cytoplasmic virion assembly complex (cVAC), the site of final virion assembly. Viral tegument, envelope, and some nonstructural proteins localize to the cVAC, and cytoskeletal filaments radiate from a microtubule organizing center in the cVAC. The endoplasmic reticulum (ER)-to-Golgi intermediate compartment, Golgi apparatus, and trans-Golgi network form a ring that outlines the cVAC. The center of the cVAC ring is occupied by numerous vesicles that share properties with recycling endosomes. In prior studies, we described the three-dimensional structure and the extensive remodeling of the cytoplasm and shifts in organelle identity that occur during development of the cVAC. The objective of this work was to identify HCMV proteins that regulate cVAC biogenesis. Because the cVAC does not form in the absence of viral DNA synthesis, we employed HCMV-infected cells transfected with synthetic small interfering RNAs (siRNAs) that targeted 26 candidate early-late and late protein-coding genes required for efficient virus replication. We identified three HCMV genes (UL48, UL94, and UL103) whose silencing had major effects on cVAC development, including failure to form the Golgi ring and dispersal of markers of early and recycling endosomes. To confirm and extend the siRNA results, we constructed recombinant viruses in which pUL48 and pUL103 are fused with a regulatable protein destabilization domain (dd-FKBP). In the presence of a stabilizing ligand (Shield-1), the cVAC appeared to develop normally. In its absence, cVAC development was abrogated, verifying roles for pUL48 and pUL103 in cVAC biogenesis.
Human cytomegalovirus (HCMV) is an important human pathogen that causes disease and disability in immunocompromised individuals and in children infected before birth. Few drugs are available for treatment of HCMV infections. HCMV remodels the interior of infected cells to build a factory for assembling new infectious particles (virions), the cytoplasmic virion assembly complex (cVAC). Here, we identified three HCMV genes (UL48, UL94, and UL103) as important contributors to cVAC development. In addition, we found that mutant viruses that express an unstable form of the UL103 protein have defects in cVAC development and production of infectious virions and produce small plaques and intracellular virions with aberrant appearances. Of these, only the reduced production of infectious virions is not eliminated by chemically stabilizing the protein. In addition to identifying new functions for these HCMV genes, this work is a necessary prelude to developing novel antivirals that would block cVAC development.
人巨细胞病毒 (HCMV) 对细胞有许多影响,包括重塑细胞质以形成细胞质病毒组装复合物 (cVAC),这是最终病毒组装的部位。病毒外壳、包膜和一些非结构蛋白定位于 cVAC,细胞骨架丝从 cVAC 中的微管组织中心辐射。内质网 (ER)-高尔基体中间区室、高尔基体和反式高尔基体网络形成一个环,环绕 cVAC。cVAC 环的中心是由许多与再循环内体具有共同特性的小泡占据。在先前的研究中,我们描述了 cVAC 形成过程中细胞质的三维结构和广泛重塑以及细胞器身份的转变。这项工作的目的是鉴定调节 cVAC 发生的 HCMV 蛋白。由于在没有病毒 DNA 合成的情况下 cVAC 不会形成,因此我们使用感染了 HCMV 的细胞转染合成的小干扰 RNA(siRNA),这些 siRNA 靶向 26 个早期晚期和晚期蛋白编码基因,这些基因是有效病毒复制所必需的。我们鉴定了三个 HCMV 基因 (UL48、UL94 和 UL103),它们的沉默对 cVAC 的发育有重大影响,包括无法形成高尔基体环和早期和再循环内体标记物的分散。为了证实和扩展 siRNA 的结果,我们构建了重组病毒,其中 pUL48 和 pUL103 与可调节蛋白不稳定结构域 (dd-FKBP) 融合。在稳定配体 (Shield-1) 的存在下,cVAC 似乎正常发育。在其不存在的情况下,cVAC 的发育被阻断,这验证了 pUL48 和 pUL103 在 cVAC 发生中的作用。
人巨细胞病毒 (HCMV) 是一种重要的人类病原体,可导致免疫功能低下个体和出生前感染的儿童患病和残疾。目前可用的治疗 HCMV 感染的药物很少。HCMV 重塑受感染细胞的内部结构,以构建一个用于组装新传染性颗粒(病毒)的工厂,即细胞质病毒组装复合物 (cVAC)。在这里,我们鉴定了三个 HCMV 基因 (UL48、UL94 和 UL103) 作为 cVAC 发育的重要贡献者。此外,我们发现表达不稳定形式 UL103 蛋白的突变病毒在 cVAC 发育和产生传染性病毒颗粒方面存在缺陷,并产生外观异常的小斑和细胞内病毒。在这些中,只有通过化学稳定化蛋白,才能消除传染性病毒颗粒的产生减少。除了确定这些 HCMV 基因的新功能外,这项工作是开发阻断 cVAC 发育的新型抗病毒药物的必要前奏。